Modalities
Platforms
DNA & Plasmid Platforms
High-quality plasmid DNA platforms
powering RNA，gene and cell therapies.
RNA Therapeutics Platforms
Integrated RNA platforms spanning mRNA,
circular RNA, and self-amplifying RNA.
LNP / tLNP Delivery Systems
Advanced lipid-based delivery systems
enabling precise in vivo targeting.
Polymer & Other Novel Delivery Systems
Next-generation non-lipid delivery systems
for emerging therapeutic needs
Protein & Peptide Manufacturing Platforms
Scalable microbial manufacturing for
proteins, nanobodies, and peptides.
GMP Manufacturing & CMC Platforms
End-to-end GMP manufacturing and CMC
support from IND to scale-up.
Services
CRDMO Service Overview
Analytical & QC
Quality & GMP
Ecosystem & Partnerships
Ecosystem & Partnerships
News
Resources
About Us
Company Profile
Corporate Culture
Facilities
Company History
Careers
contact
Catalog Order
CN
菜单
搜索
Modalities
Cancer & Therapeutic Immunotherapies
In Vivo Cell Therapies
Ex Vivo Cell Therapy
Protein Replacement Therapies
Gene Editing (RNA-enabled)
Prophylactic Infectious Disease Vaccines
Protein & Peptide Therapeutics
Platforms
DNA & PlasmidPlatforms
RNA Therapeutics Platform
LNP / tLNP Delivery Systems
Polymer & Other Novel Delivery Systems
Protein & Peptide Manufacturing Platforms
GMP Manufacturing & CMC Platforms
Services
Services Overview
Analytical Development & QC
Quality Grades & GMP Readiness
Ecosystem & Partnerships
News
Resources
Learning Center
About Us
Company Profile
Corporate Culture
Facilities
Company History
Careers
contact
Contact Us
Catalog Order
News
June 1 , 2025
CATUG’ s Suzhou CDMO Facility Successfully Passes EU QP Audit
November 13 , 2024
CATUG Biotechnology Supports BodMed's Positive Clinical Progress with BMD003, a First-in-Class non-LNP, non-Viral Inhaled mRNA Freeze-Dried Formulation
«
1
2
»
contact us